Sunday, April 20, 2025
Home 2023

Yearly Archives: 2023

2020 Watch List

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Editor / Curator -
2023 Watch List

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical...

Editor / Curator -
2023 Watch List

Video: New Topical Drug Delivery System, NeuroDirect™

Editor / Curator -
2023 Watch List

Topical PTSD Drug Poised for Human Trials.

Editor / Curator -
Uncategorized

Ketamine and Yale University

Editor / Curator -
Zappy Zapolin, Lamar Odom, Roland Rick Perry
2023 Watch List

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.

Editor / Curator -
AI Artificial Intelligence

Khan Academy’s AI Pilot Program.

Editor / Curator -
Biotech News

Pivotal Clinical Trials: Frequently Asked Questions (Sofpromed).

Editor / Curator -
2023 Watch List

Adding Cardiol Therapeutics (CRDL) $0.59 to Watch List.

Editor / Curator -
Accelerator

Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into...

Editor / Curator -
1...111213...18Page 12 of 18

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator -
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.